How to Test Your NAD+ Levels: The Complete Guide to NAD+ Blood Testing (2026)

NAD+ (nicotinamide adenine dinucleotide -- a coenzyme found in every living cell that drives energy production, DNA repair, and cellular signaling) has become the most talked-about molecule in longevity science. It declines with age. Supplementation with precursors like NMN can raise it. And now, a growing number of companies claim they can measure it from a blood sample.

But here is the uncomfortable reality: NAD+ testing in 2026 is still a field without standardized reference ranges, universal measurement methods, or consensus on what "optimal" levels actually mean. That does not make it useless -- it makes it complicated.

This guide breaks down every major NAD+ testing option, what each one actually measures, how results compare across methods, and what the clinical evidence says about interpreting your numbers.

TL;DR

• NAD+ can be measured in whole blood, plasma, serum, or intracellularly in PBMCs (white blood cells) -- each method gives different numbers that cannot be directly compared
• Jinfiniti's intracellular NAD+ test and ChromaDex's TruNiagen blood panel are the two most accessible consumer options in 2026
• Normal NAD+ ranges vary dramatically by testing method: intracellular PBMC levels typically range from ~20-50 micromolar, while whole blood NAD+ concentrations can be measured in the hundreds of micromolar range
• NMN supplementation at 600-900 mg/day has been shown to significantly increase blood NAD+ levels within 30-60 days in clinical trials
• There are no universally accepted "optimal" NAD+ ranges -- reference ranges are lab-specific and based on limited population data
• Testing is most useful for tracking your own changes over time (using the same lab and method), not for comparing your numbers to someone else's

Why NAD+ Testing Is Harder Than a Standard Blood Panel

When your doctor orders a cholesterol panel, the lab uses standardized methods with decades of population data behind the reference ranges. Everyone agrees on what "high LDL" means, give or take a few points.

NAD+ testing has none of that infrastructure. Here is why:

NAD+ exists in multiple compartments. The NAD+ in your blood plasma is not the same pool as the NAD+ inside your cells. Intracellular NAD+ (the amount inside your cells, where it does its metabolic work) is the functionally relevant measurement -- it drives sirtuin activity (a family of proteins that regulate cellular health and DNA repair), PARP-mediated DNA repair (a process where PARP enzymes use NAD+ to fix damaged DNA), and mitochondrial function. But intracellular testing requires isolating specific cell types, adding complexity and cost.

NAD+ degrades rapidly ex vivo. Once blood is drawn, NAD+ begins breaking down. Time to processing, transport temperature, and preservation method all affect results (Cuny et al., Analytical Biochemistry, 2021).

No universal reference ranges exist. Different labs use different assay methods (LC-MS/MS, enzymatic cycling assays, ELISA), different sample types (whole blood, plasma, PBMCs), and different units. A "normal" result from one lab cannot be meaningfully compared to another.

Key Takeaway: NAD+ testing is not like checking your hemoglobin A1c. The field lacks standardization, which means you need to understand what your specific test measures and use it for longitudinal tracking rather than absolute benchmarks.

What NAD+ Tests Actually Measure: The Four Sample Types

Not all NAD+ tests are measuring the same thing. The sample type determines what pool of NAD+ you are assessing, and results from different sample types are not interchangeable.

Whole Blood NAD+

Whole blood includes red blood cells, white blood cells, platelets, and plasma. Red blood cells (erythrocytes) contain significant amounts of NAD+ and NADH (the reduced form of NAD+ that carries electrons for energy production), so whole blood measurements tend to produce the highest absolute numbers.

What it tells you: A composite picture of all blood-compartment NAD+. This is what the Yi et al. 2023 multicenter NMN trial measured -- and they noted that their blood NAD concentration data represented "the total concentration of NAD+ plus NADH in serum" (Yi et al., GeroScience, 2023).

Limitation: Heavily influenced by red blood cell count. Someone with polycythemia (elevated red blood cell count) could show high NAD+ that reflects hematology, not metabolic health.

Plasma NAD+

Plasma is the liquid portion of blood after cells are removed. Plasma NAD+ levels are much lower than whole blood because you have removed the cell-bound NAD+.

What it tells you: Extracellular NAD+ availability -- the NAD+ circulating between tissues.

Limitation: Represents a tiny fraction of total body NAD+ and is highly susceptible to preanalytical degradation. Levels shift with food intake, exercise, and circadian rhythm (NAD+ naturally fluctuates throughout the day).

Serum NAD+

Serum is plasma with clotting factors removed. In practice, serum and plasma NAD+ values are similar, though the clotting process can release some intracellular NAD+ from platelets, slightly inflating the measurement.

Intracellular NAD+ (PBMCs)

PBMCs (peripheral blood mononuclear cells -- a category of white blood cells including lymphocytes and monocytes that can be isolated from a blood draw) represent the gold standard for functional NAD+ assessment. By isolating these immune cells and measuring the NAD+ inside them, labs get a snapshot of intracellular NAD+ -- the pool that actually drives cellular metabolism.

What it tells you: The most functionally relevant measurement. This is the NAD+ that fuels sirtuins, PARPs, and CD38 (a membrane enzyme that breaks down NAD+ and increases with age, contributing to age-related NAD+ decline).

Limitation: Requires cell isolation, which introduces handling variability. The PBMC population itself changes with immune status -- an active infection could shift your NAD+ reading independent of your supplementation protocol.

NAD+ Testing Services Compared (2026)

The consumer NAD+ testing market has consolidated around a few key players. Here is what each one offers and how they differ.

Jinfiniti Intracellular NAD+ Test

Jinfiniti (founded by Dr. Jin-Xiong She, an immunologist at Augusta University) offers what is currently the most widely used consumer NAD+ test. Their proprietary assay measures intracellular NAD+ levels from a dried blood spot sample collected at home.

How it works: Finger prick, dried blood spot collection card, mailed to their lab. They isolate the cellular fraction and measure NAD+ using an enzymatic assay.

What you get: Intracellular NAD+ in micromolar units, categorized as suboptimal, optimal, or above optimal. Their optimal range is approximately 40+ micromolar.

Cost: $149-199 per test, with discounts for bundles.

Strengths: At-home collection, intracellular measurement (more functionally relevant than plasma), 7-10 day turnaround, large user dataset.

Limitations: Proprietary assay -- results cannot be compared to clinical labs. Dried blood spot NAD+ stability not independently validated in peer-reviewed literature. Reference ranges based on their own population data, not prospective cohort studies.

ChromaDex TruNiagen Blood Panel

ChromaDex, the company behind the NR (nicotinamide riboside) supplement Tru Niagen, offers a blood panel that measures NAD+ and related metabolites. This test is positioned as a companion to their NR supplement, though it can be used by anyone.

How it works: Venous blood draw at a partner lab (Quest Diagnostics or similar), processed using LC-MS/MS (liquid chromatography-tandem mass spectrometry -- a sensitive technique that identifies molecules by mass-to-charge ratio).

What you get: Whole blood NAD+ plus metabolites including NMN, NR, nicotinamide (NAM), and NAAD (nicotinic acid adenine dinucleotide -- identified by Trammell et al. as a sensitive biomarker of NAD+ repletion) (Trammell et al., Nature Communications, 2016).

Cost: $150-250, plus blood draw fees.

Strengths: LC-MS/MS (analytical gold standard), multiple metabolites, controlled venous sample.

Limitations: Requires in-person lab visit. Measures whole blood, not intracellular. Designed around the NR pathway, relevant for anyone taking NAD+ precursors but optimized for NR metabolism specifically.

Clinical Lab Testing (Quest, LabCorp, Specialty Labs)

Some physicians can order NAD+ testing through clinical laboratories. Quest Diagnostics has added NAD+ testing in partnership with ChromaDex. Standard venous blood draw, processed at a clinical lab. Panels range from NAD+ only to the full NAD+ metabolome (NAD+, NADH, NMN, NR, NAM, NAAD, ADPR). Cost runs $200-500+, and insurance generally does not cover it.

Strengths: Clinical-grade sample handling, physician oversight, integration with other blood panels.

Limitations: Availability varies by region. Most general practitioners are unfamiliar with NAD+ testing and cannot interpret results. No standardized reference ranges across labs.

What "Normal" NAD+ Levels Look Like by Age

This is where things get complicated. There are no universally accepted NAD+ reference ranges stratified by age in the way that exists for, say, testosterone or vitamin D. The data we have comes from a handful of studies measuring NAD+ in different tissues, using different methods, across relatively small cohorts.

Here is what the research shows:

The Massudi Study: NAD+ in Human Tissue

The landmark study on age-related NAD+ decline comes from Massudi et al. (2012), who measured NAD+ in human skin tissue samples across a range of ages. They found a strong inverse correlation between NAD+ concentration and age in males (r = -0.769, p = 0.0007) and a significant decline in post-pubescent females (r = -0.537, p = 0.01) (Massudi et al., PLoS One, 2012).

The key finding: NAD+ levels declined progressively throughout adulthood, with the steepest drops occurring between ages 40-60. By age 60+, tissue NAD+ levels were roughly 50% lower than in young adults.

However, this study measured tissue NAD+ -- not blood NAD+. You cannot extrapolate these tissue values directly to what a blood test would show.

The Zhu Study: NAD+ in Human Brain

Zhu and Chen (2018) used advanced MRS imaging (magnetic resonance spectroscopy -- a non-invasive technique that measures metabolite concentrations in living tissue using MRI technology) to measure NAD+ in the human brain across three age groups: young adults (21-26 years), middle-aged adults (33-36 years), and older adults (59-68 years). They observed age-dependent declines in intracellular NAD+ concentration, the NAD+/NADH ratio (the balance between the oxidized and reduced forms of the coenzyme, which reflects metabolic efficiency), and total NAD content (Zhu & Chen, Frontiers in Aging Neuroscience, 2018).

Why CD38 Matters for Your Results

The primary driver of age-related NAD+ decline appears to be CD38, a membrane enzyme whose expression increases with age and chronic inflammation. Camacho-Pereira et al. (2016) demonstrated that CD38 is both necessary and sufficient for age-related NAD+ decline in animal models -- and critically, that CD38 also degrades NMN, the very precursor used to replenish NAD+ (Camacho-Pereira et al., Cell Metabolism, 2016).

What this means for testing: Two people of the same age could have very different NAD+ levels depending on their CD38 expression, which is influenced by inflammatory status, body composition, and metabolic health. This is one reason why a single "normal range by age" table does not capture the full picture.

Approximate NAD+ Trends by Age (Based on Available Data)

The following is a rough synthesis -- not a clinical reference range. Treat these as directional trends, not diagnostic thresholds.

Key Takeaway: NAD+ declines with age, but the rate varies dramatically between individuals based on inflammation, metabolic health, body composition, and lifestyle. Two 50-year-olds can have very different NAD+ levels. Testing your own baseline matters more than comparing yourself to population averages.

How NMN Supplementation Changes Measurable NAD+ Levels

If you are taking NMN or another NAD+ precursor, you probably want to know: does supplementation actually show up on a test? The clinical evidence says yes -- but the magnitude and timeline vary.

The Yi et al. Multicenter Trial (2023)

The most rigorous evidence comes from a randomized, multicenter, double-blind, placebo-controlled trial by Yi et al. (2023). This study enrolled healthy middle-aged adults and tested NMN at multiple doses (300, 600, and 900 mg/day) against placebo over 60 days.

Key findings:

• Blood NAD+ levels increased significantly in all NMN groups at both day 30 and day 60 compared to placebo and baseline (p less than or equal to 0.001 for all comparisons)
• The 600 mg and 900 mg doses produced the highest NAD+ concentrations, suggesting a dose-response relationship that plateaus at higher doses
• The effect was detectable by day 30 and maintained through day 60
• Blood NAD concentration in this study represented total NAD+ plus NADH in serum

(Yi et al., GeroScience, 2023)

This study is particularly relevant because it used the 600 mg NMN dose that most evidence supports and demonstrated consistent NAD+ elevation across multiple clinical sites.

The Pencina MIB-626 Trial (2023)

Pencina et al. studied MIB-626, a microcrystalline formulation of NMN, in middle-aged and older adults. Using LC-MS/MS measurement, they found dose-related increases in blood NAD+ levels -- 1.7-fold at the lower dose and 3.7-fold at the higher dose above baseline by day 14 (Pencina et al., Journal of Gerontology A, 2023).

NR Supplementation Data

For comparison, nicotinamide riboside (NR) has also demonstrated measurable NAD+ increases: Trammell et al. (2016) showed a single NR dose could increase blood NAD+ up to 2.7-fold (PMID: 27721479), and Martens et al. (2018) confirmed chronic NR supplementation (1,000 mg/day for 6 weeks) effectively stimulated NAD+ metabolism in older adults (PMID: 29599478).

What to Expect on Your Test Results

Based on the clinical trial data, here is what supplementation-related NAD+ changes typically look like:

Key Takeaway: NMN supplementation at 600 mg/day consistently elevates blood NAD+ in clinical trials within 30-60 days. If your test shows no increase after 60 days of consistent supplementation, consider whether the issue is the test method, the supplement quality, or absorption factors.

How to Get the Most Out of NAD+ Testing

If you decide to test, here is how to maximize the usefulness of your results.

Before Your Test

Consistency is everything. NAD+ levels fluctuate with circadian rhythm, food intake, exercise, and stress, so standardize your conditions:

• Test at the same time of day each time (morning fasting is ideal)
• Fast for at least 8-12 hours before the test
• Avoid intense exercise for 24 hours prior
• Take your supplements at the usual time -- do not skip or double up
• Use the same testing service every time -- switching labs makes results incomparable

Interpreting Your Results

Your absolute number matters less than your trend. Here is a framework:

1. Establish a baseline. Test before starting any NAD+ precursor supplementation. This is your personal reference point.
2. Retest after 60-90 days of consistent supplementation. The Yi et al. data shows significant changes by day 30, but 60-90 days gives a more stable reading.
3. Compare to yourself, not to others. A Jinfiniti result of 35 micromolar and a ChromaDex result of 35 micromolar do not mean the same thing -- they are measuring different pools with different methods.
4. Look at the direction, not just the number. A 40% increase from your baseline is meaningful regardless of whether your absolute level is "optimal" by the lab's proprietary range.
5. Consider the full picture. NAD+ levels are one data point. Pair them with other longevity blood biomarkers and biological age testing for a more complete assessment.

Testing Frequency

For most people tracking a supplementation protocol:

• Baseline test before starting supplementation
• Follow-up at 60-90 days to confirm NAD+ elevation
• Every 6-12 months thereafter to confirm sustained levels
• Retest if you change your supplement brand, dose, or protocol

Monthly testing is unnecessary and generates noise that mimics real change. Spacing tests further apart gives more signal relative to natural day-to-day variability.

The Limitations You Need to Understand

NAD+ testing can be valuable -- but only if you understand what it cannot tell you.

No Proven Link Between Blood NAD+ Levels and Health Outcomes

This is the biggest limitation. No prospective study has established that a specific blood NAD+ level predicts disease risk, mortality, or healthspan in the way that, for example, HbA1c predicts diabetes complications. The tissue-level studies (Massudi, Zhu) show age-related decline, and the supplementation trials show that precursors raise blood levels -- but the clinical bridge between "higher NAD+ on a blood test" and "better health outcomes" has not been definitively established in large human cohorts.

Testing Method Variability

The same person tested on the same day by two different labs using two different methods will likely get two different numbers. This is not because one lab is wrong -- it is because they are measuring different things (intracellular vs. whole blood, enzymatic assay vs. LC-MS/MS). This lack of standardization is the single biggest barrier to making NAD+ testing clinically actionable.

Preanalytical Instability

NAD+ degrades rapidly once blood is drawn. Temperature, time to processing, and preservation method all matter. At-home finger-prick tests (like Jinfiniti) rely on the dried blood spot format to stabilize the sample, but the validation of this approach for NAD+ specifically is less extensive than for traditional venous blood draws processed immediately.

Individual Variability

NAD+ levels are influenced by genetics, circadian rhythm, diet, exercise, inflammatory status, body composition, and medication use. A single test captures one snapshot of a constantly moving target.

What NAD+ Levels Do Not Tell You

Even a "high" NAD+ level does not tell you how efficiently your cells are using that NAD+, whether your sirtuins are actually activated, how much NAD+ is reaching specific tissues (brain, liver, muscle), or your overall pace of aging (for that, look at biological age testing).

Key Takeaway: NAD+ testing is a useful tracking tool for supplementation protocols, but it is not a health diagnostic. Treat it as one input alongside blood biomarkers, biological age tests, and functional health measures -- not as a standalone verdict on your longevity trajectory.

FAQ

How much does an NAD+ test cost?

Consumer tests cost $149-250 per test. Jinfiniti runs $149-199, ChromaDex's panel is $150-250 plus blood draw fees, and clinical lab panels range $200-500+. Insurance generally does not cover NAD+ testing. Multi-test bundles offer discounts for longitudinal tracking.

Can my regular doctor order an NAD+ test?

Technically yes, but most general practitioners are unfamiliar with NAD+ testing and cannot interpret results in the context of NAD+ biology. Look for a functional medicine or longevity-focused physician, or use direct-to-consumer tests from Jinfiniti or ChromaDex, which do not require a doctor's order.

How often should I test my NAD+ levels?

For most people: baseline before supplementation, a follow-up at 60-90 days, then every 6-12 months. More frequent testing generates noise without meaningful additional data. NAD+ levels fluctuate naturally throughout the day and across days, so monthly testing can produce apparent changes that are just normal variation.

Are at-home NAD+ finger-prick tests accurate?

Dried blood spot tests are validated for many analytes, though NAD+-specific validation data is less extensive. Jinfiniti's test is widely used and has a large dataset, but its proprietary methodology has not been independently validated against reference LC-MS/MS methods in peer-reviewed studies. Likely reliable for tracking trends within their system, but not directly comparable to clinical lab results.

What is a good NAD+ level?

This depends entirely on the testing method. On Jinfiniti's assay, approximately 40+ micromolar is categorized as optimal. On whole blood tests, different ranges apply. Science has not yet established clinically validated optimal NAD+ ranges linked to health outcomes. Focus on your personal trend rather than a specific number.

Will NMN supplementation definitely raise my NAD+ levels on a test?

Clinical trial data is strongly supportive. Yi et al. (2023) showed statistically significant NAD+ increases in all NMN-treated groups at both 30 and 60 days. However, individual responses vary based on baseline NAD+ status, absorption, dose, CD38 activity, and other factors. If you take 600 mg NMN daily for 60+ days and see no change on a validated test, consider supplement quality, timing (take with first meal), or discussing with a physician.

Is intracellular NAD+ testing better than whole blood testing?

Intracellular testing (like Jinfiniti's PBMC-based assay) measures the NAD+ that is actually doing metabolic work inside your cells, making it arguably more functionally relevant. Whole blood testing (like the ChromaDex panel) gives a broader view and can measure multiple metabolites simultaneously. Neither is objectively "better" -- they answer different questions. For tracking supplementation response, intracellular testing may be more sensitive. For understanding your full NAD+ metabolome, whole blood LC-MS/MS panels offer more data points.

Can I test NAD+ levels in specific organs like my brain or liver?

Not through a standard blood test. The Zhu and Chen (2018) brain NAD+ measurements used MRS imaging in a research setting -- not commercially available. Blood NAD+ is a proxy for systemic status but does not directly reflect tissue-specific concentrations.

The Bottom Line

NAD+ testing is real, commercially available, and scientifically grounded -- but it is still an emerging field. The technology works. NMN and NR supplementation demonstrably raise measurable NAD+ levels. And tracking your levels over time can confirm that your protocol is doing what you intend.

The science supports using NAD+ testing as a longitudinal tracking tool -- test before supplementation, test again after 60-90 days, then periodically to confirm sustained elevation. Use the same lab and method every time. Compare yourself to yourself.

What the science does not yet support is using a single NAD+ number as a definitive health marker the way you would use blood pressure or fasting glucose. The field needs standardized methods, large prospective cohorts linking specific levels to outcomes, and consensus reference ranges before NAD+ testing reaches that level of clinical maturity.

In the meantime, the most actionable approach combines NAD+ testing with broader longevity biomarker panels and biological age testing. NAD+ levels are one piece of a much larger picture -- and the picture is always more useful than any single pixel. For a comprehensive evidence ranking of all major NAD+ precursors and longevity compounds, browse the Compound Index.

Related Reading

• What Is NMN? The Complete Beginner's Guide
• NAD+ Decline by Age: What Happens to Your Cells
• NMN Dosage Guide: How Much Should You Take?
• Biological Age Testing: The Complete Guide
• Longevity Blood Tests and Biomarkers Worth Tracking
• NAD+ Precursors Compared: NMN vs. NR vs. Niacin

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.